News

Steve McMichael, astro defensivo del equipo de los Bears de Chicago que ganó el recordado Super Bowl de 1985, ha fallecido ...
US-based biotechnology company Therini Bio has reported positive results from a Phase Ia trial of THN391, a potential ...
Osteoarthritis (OA), a common degenerative joint disease that affects millions of people worldwide, particularly targets the ...
Stanford researchers replicated a pain transmission pathway that could help improve future pain treatments, while a “digital ...
Nature has developed a unique structure as a scaffold for almost all nerve cells: the membrane-associated periodic skeleton ...
In preclinical models of PD, GT-02287 restored GCase enzymatic function, reduced ER stress, lysosomal and mitochondrial pathology, aggregated α-synuclein, neuroinflammation and neuronal death, as well ...
Memory formation, storage, and retrieval are fundamental processes that define who we are and how we interact with the world.
SIRT2, an enzyme previously overlooked in astrocytic GABA production, may be crucial for distinguishing the specific effects ...
A pioneering study has unveiled a revolutionary technique that enhances stem cell therapy for neurodegenerative diseases by ...
A new study reveals that sleep not only consolidates existing memories but also primes the brain for future learning.
The U.S. Food and Drug Administration notified consumers of a recall for a “healthy aging” supplement.The recall, initiated due to an undeclared allergen, has been officially labeled a Class 1 recall, ...
Therini Bio intends to commence two Phase 1b trials imminently, evaluating THN391 for the treatment of patients with Alzheimer’s Disease and Diabetic Macular Edema.